Article Information
History
- May 5, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Zixin Hu1,2,
- Qiyang Ge3,
- Li Luo4,
- Tao Xu7,
- Kai Zhang5,
- Henry H Lu6,
- Wei Li3,
- Eric Boerwinkle7,
- Li Jin1,2 and
- Momiao Xiong7,*
- 1State Key Laboratory of Genetic Engineering and Innovation Center of Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China
- 2Human Phenome Institute, Fudan University, Shanghai, China
- 3The School of Mathematic Sciences, Fudan University, Shanghai, China
- 4Department of Internal Medicine, University of New Mexico, USA
- 5Department of Environmental Health Sciences, University at Albany, State University of New York, NY 12144, USA
- 6Sanofi Pharmaceuticals. Bridgewater, NJ 08807
- 7Department of Biostatistics and Data Science, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
- ↵*Address for correspondence and reprints: Dr. Momiao Xiong, Department of Biostatistics and Data Science, School of Public Health, The University of Texas Health Science Center at Houston, P.O. Box 20186, Houston, Texas 77225, (Phone): 713-500-9894, (Fax): 713-500-0900, E-mail: Momiao.Xiong{at}uth.tmc.edu.
Posted May 05, 2021.
Population Vaccine Effectiveness and its Implication for Control of the Spread of COVID-19 in the US
